Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @MDEpiNet_ppp
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MDEpiNet_ppp
-
MDEpiNet proslijedio/la je Tweet
Abstract deadline just extended for
#IDEAL2020@CSR_Bris@ndorms@BMJSurgTech@surgicalMIC@RCSnews@murat_akkulak@SITU_Oxford@OxSI2020@MDEpiNet_ppp@ArtsyTwits@ag_kolias@ArtsyTwits@MarionKCampbell@mldbneuro@AshokHandaOx@hani_marcus@FeiShaan@BlazebyJ@janetmartinwhohttps://twitter.com/IDEALCollab/status/1223282345798787072 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Transapical mitral valve replacement using
@AbbottNews#device in the real world. Hoping post approval ‘registry’ in Europe will become true surveillance registry to ensure long-term safety @IDEALCollab @MDEpiNet_ppphttps://www.dicardiology.com/article/worlds-first-transcatheter-mitral-valve-approved-europe …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Proud of being part of this rising new journal on innovative research in surgery!
#GermanVasc further pushes the quality improvement initiative in PAOD treatment together with@MDEpiNet_ppp@MatthiasTrenner@ArtsyTwits Read the study protocol open access! https://sit.bmj.com/content/2/1/e000020 …pic.twitter.com/KvpUh8JAUN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Mentoring academy
@WeillCornell@WCMMentoring townhall by Dean@AugustineMKChoi and consistent and strong message to be honest with mentees! Mentoring is a challenge in modern academic medicine with few incentives- comes from the heartHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
@BMJSurgTech is led by@McCullochP and@ArtsyTwits Dr. McCulloch serves as Professor at the@UniofOxford and the Chair of the@IDEALCollab while Dr. Sedrakyan is a Professor@WeillCornell and the leader@MDEpiNet_ppppic.twitter.com/znqWM1Jw5O
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
We have an all star cast of amazing editors from many interventional surgical fields and from across the globe.
@AWBeckMD@EBMUrology@ag_kolias@dliebesk@andrea_pusic@CharlesRardin@heatheryeomd@jdimick1@jimhumd@artsytwits@McCullochP to name a few!pic.twitter.com/91VruSOjGr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Still time to submit abstracts - until 1st Feb for our
#IDEAL2020 Conference in Amsterdam in June https://www.radboudumc.nl/en/education/events/all-events/10353-ideal-2020 … See topics below:@NlIdeal@MaroeskaRovers@NDSurgicalSci@SITU_Oxford@NDORMS@OxSI2020@MDEpiNet_ppp@RCSnews@surgicalMICpic.twitter.com/C6IV7w0r4i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
37,914 patients treated between 2010-2018 were included in this very robust propensity score matched analysis of longitudinal population-based health insurance claims to determine long-term survival and relevant outcomes after paclitaxel-coated devices! https://doi.org/10.1016/j.ejvs.2019.12.034 …pic.twitter.com/fuFpfriUNm
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
This is the long-term
#paclitaxel elluting#devices study that regulators needed@FDADeviceInfo very powerful study using European data@MDEpiNet_ppp@NESTccMedTechhttps://twitter.com/VASCevidence/status/1215158038551764992 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
will be a fantastic
@IDEALCollab meeting in#Amsterdam many people attending from@MDEpiNet_ppp! https://twitter.com/IDEALCollab/status/1207972380775194625 …pic.twitter.com/rPDpY6SYZY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Eric Chen from
@AbbottGlobal:#medicaldevices market reached $425 billion in 2018 and to exceed $600 billion in 2025@MDEpiNet_ppp@NESTccMedTech https://twitter.com/ArtsyTwits/status/1204653733306486785 …pic.twitter.com/eLI95jPN2T
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Thank you
@ArtsyTwits . Many keypersons were learning about#RWE ,@MDEpiNet_ppp , and important of international collaborations. https://twitter.com/ArtsyTwits/status/1205025762006335488 …pic.twitter.com/mD1gyWxkh8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Another day of
#RWE discussions at http://www.hosp.ncgm.go.jp/en/index.html successful launch of@MDEpiNet_ppp in Japan. Fantastic talks by@ksase@cbdrh1 and@hiro_stat over 200 Various registry leaders in Japan participating in the meetingpic.twitter.com/AzRdpQTUmw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Excellent opportunities for real world evidence in Japan.
@MDEpiNet_ppp working with@ksase,@hiro_stat and the leadership of NCGM to launch MDEPINet-Japan http://www.hosp.ncgm.go.jp/en/index.html https://twitter.com/ksase/status/1204561696984948737 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Excellent article concerning regional differences in abdominal aortic aneurysm repair in Germany! Congratulations to the team of
@VascularTUM for publishing this real-world evidence study in VASA!@MDEpiNet_ppp@MatthiasTrenner https://www.hogrefe.de/produkte/zeitschriften/vas …pic.twitter.com/5DJm9t2X8w
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Very interesting upcoming project of
@MatthiasTrenner concerning arch pathologies with aberrant right subclavian artery#MAC2019@MDEpiNet_ppppic.twitter.com/k8O6KaOS8g
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
#GDPR clearly affects our major international#medicaldevice collaborations but we have some solutions using distributed research approaches@MDEpiNet_ppp@NESTccMedTechhttps://twitter.com/EricTopol/status/1197660283897909248 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Congratulations to
@jimhumd@WeillCornell for study funding approval. Find study info here.http://bit.ly/2QtttnNHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
Fantastic success for SPARED http://mdepinet.org/spared-2/ and technology assessments for
#prostatecancer devices! thank you@jimhumd for leadership! Important for sustainability approach@MDEpiNet_ppp@FDADeviceInfohttps://twitter.com/jimhumd/status/1196850920677691393 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MDEpiNet proslijedio/la je Tweet
At
@MDEpiNet_ppp ICVR meeting Sal Scali from@uflorida presenting advanced Volume threshold analysis for AAA at#veith2019 no center level V-O relationship for#EVAR. Huge implications for practice and regulationpic.twitter.com/OH4oFlgJvR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
See
